In terms of prognosis, studies have shown that high concentrations of anti-HER2 autoantibodies are associated with a good prognosis in patients with invasive breast cancer, possibly due to enhanced humoral immunity against breast cancer (100). Here, ERBB2 is linked to breast cancer.